| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/24/1996 | EP0707650A1 Process for producing relaxin |
| 04/24/1996 | EP0707649A1 Cisplatin resistance gene and uses therefor |
| 04/24/1996 | EP0707648A1 Platelet glycoprotein v gene and uses |
| 04/24/1996 | EP0707647A1 Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis |
| 04/24/1996 | EP0707646A1 Vectors for genetically engineered cells that produce insulin in response to glucose |
| 04/24/1996 | EP0707645A1 Novel, recombinantly produced spider silk analogs |
| 04/24/1996 | EP0707644A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 04/24/1996 | EP0707638A1 Regulatable nucleic acid therapeutic and methods of use thereof |
| 04/24/1996 | EP0707636A1 Methods and compositions for the removal of viruses and uses thereof |
| 04/24/1996 | EP0707634A1 New stromal cell lines from human bone marrow and their use |
| 04/24/1996 | EP0707599A1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
| 04/24/1996 | EP0707598A1 Human spasmolytic polypeptide in glycosylated form |
| 04/24/1996 | EP0707597A1 ANTIGENIC POLYPEPTIDES OF $i(T. OVIS) AND VACCINES CONTAINING SUCH POLYPEPTIDES |
| 04/24/1996 | EP0707596A1 Conjugation-stabilized polypeptide compositions |
| 04/24/1996 | EP0707595A1 Peptidase resistant thrombin receptor peptide ligand |
| 04/24/1996 | EP0707594A1 Separation of proteins |
| 04/24/1996 | EP0707490A1 Neuropeptide y antagonists and agonists |
| 04/24/1996 | EP0707489A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 04/24/1996 | EP0625194B1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide |
| 04/24/1996 | EP0490951B1 Fragments of nucleic acids derived from an appropriate mycobacteria genome, their applications in the diagnosis of mycobateria infections and plasmides containing said fragments |
| 04/24/1996 | EP0489070B1 Novel inhibitors of thrombin |
| 04/24/1996 | EP0429626B1 Synthetic peptides for use in vivo in thrombus detection |
| 04/24/1996 | CN1121312A Chlamydia vaccine and process |
| 04/24/1996 | CN1121077A New peptide compounds derived from boronic acid, process for preparing them and pharmaceutical compositions containing them |
| 04/23/1996 | US5510474 Plant ubiquitin promoter system |
| 04/23/1996 | US5510472 Production of recombinant human interferon-beta2 |
| 04/23/1996 | US5510466 Scavenger receptor protein and antibody thereto |
| 04/23/1996 | US5510462 IL-1βprotein precursor |
| 04/23/1996 | US5510461 pp: A newly identified CD45-associated protein |
| 04/23/1996 | US5510460 Peptide process |
| 04/23/1996 | US5510459 Glucagon antagonists |
| 04/23/1996 | US5510458 CRF antagonists |
| 04/23/1996 | US5510418 Glycosaminoglycan-synthetic polymer conjugates |
| 04/23/1996 | US5510333 Inhibitors of Cathepsin G and elastase for preventing connective tissue degradation |
| 04/23/1996 | US5510332 Peptide of from 4 to 13 amino acid residues |
| 04/23/1996 | US5510331 Antihypertensive peptides |
| 04/23/1996 | US5510328 Compositions that inhibit wound contraction and methods of using same |
| 04/23/1996 | US5510327 Containing tumor cytotoxic factor, basic amino acid or salt thereof, organic or inorganic salt |
| 04/23/1996 | US5510270 Generating pattern of light and dark areas by selectively irradiating surface areas; deprotecting; contacting with receptor to identify oligonucleotide showing complementarity to receptor |
| 04/23/1996 | US5510264 Antibodies which bind meningitis related homologous antigenic sequences |
| 04/23/1996 | US5510263 Growth of pancreatic islet-like cell clusters |
| 04/23/1996 | US5510261 Method of controlling the degradation of glycoprotein oligosaccharides produced by cultured Chinese hamster ovary cells |
| 04/23/1996 | US5510260 Prolactin secreting cell line and method of obtaining the same |
| 04/23/1996 | US5510259 Isolated, purified dna having nucleotide sequence coding for said molecule |
| 04/23/1996 | US5510256 Genetically engineered dna sequences which do not code for a lymphocyte membrane polypeptide |
| 04/23/1996 | US5510255 Plant fatty acid synthases |
| 04/23/1996 | US5510249 Fusion of signal peptide, a leader peptide, a heterogenous protein or polypeptide; genetic engineering |
| 04/23/1996 | US5510241 Using monoclonal antibodies |
| 04/23/1996 | US5510240 Method of screening a peptide library |
| 04/23/1996 | US5510239 One of the intersugar linkages between nuclotide units of the oligonuclotide is phosphorothioate linkage |
| 04/23/1996 | US5510238 Production of human T-cell leukemia (lymphotropic) retrovirus (HTLV-I) envelope protein fragments in bacteria and use in seroepidemiological studies |
| 04/23/1996 | US5510121 Containing a synthetic hydrophilic polymer |
| 04/23/1996 | US5510106 Immunological response |
| 04/23/1996 | CA1338262C Antitumor antibiotic kedarcidin |
| 04/23/1996 | CA1338260C Human protein s, a plasma protein regulator of hemostasis |
| 04/19/1996 | CA2160753A1 Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
| 04/19/1996 | CA2138425A1 Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy |
| 04/18/1996 | WO1996011279A2 Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system |
| 04/18/1996 | WO1996011278A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 04/18/1996 | WO1996011277A1 Microorganisms as therapeutic delivery systems |
| 04/18/1996 | WO1996011274A1 Chimeric papillomavirus-like particles |
| 04/18/1996 | WO1996011273A1 Papillomavirus vaccine |
| 04/18/1996 | WO1996011272A2 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 04/18/1996 | WO1996011271A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/18/1996 | WO1996011270A1 Cloning and characterizing of genes associated with long-term memory |
| 04/18/1996 | WO1996011269A2 Tie-2 ligands, methods of making and uses thereof |
| 04/18/1996 | WO1996011268A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 04/18/1996 | WO1996011267A1 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof |
| 04/18/1996 | WO1996011265A1 Cis-acting sequences for intracellular localization of rna |
| 04/18/1996 | WO1996011260A1 Patched genes and their use |
| 04/18/1996 | WO1996011259A1 TGF-β1, ACTIVIN RECEPTORS 1 AND 3 |
| 04/18/1996 | WO1996011214A1 Peptides and pharmaceutical compositions comprising them |
| 04/18/1996 | WO1996011213A1 Dimeric il-4 inhibitors |
| 04/18/1996 | WO1996011212A1 Novel receptor-type tyrosine kinase ligand |
| 04/18/1996 | WO1996011207A1 Compositions and methods for interfering with hepatitis b virus infection |
| 04/18/1996 | WO1996011205A1 Peptide nucleic acid conjugates |
| 04/18/1996 | WO1996011017A1 A novel inhibitor of hepatitis b virus replication |
| 04/18/1996 | WO1996011012A1 Hematopoietic cell l-selectin ligand (hll) and therapeutics thereof |
| 04/18/1996 | WO1996010997A1 Hepatitis virus vaccines |
| 04/18/1996 | WO1996010911A1 Cytokine designated lerk-6 |
| 04/18/1996 | WO1996007739A3 Interleukin-1 type 3 receptors |
| 04/18/1996 | WO1996005288A3 T cell activation |
| 04/18/1996 | WO1996001317A3 Mammalian peroxisome proliferator-activated receptors and uses thereof |
| 04/18/1996 | CA2202472A1 Hematopoietic cell l-selectin ligand (hll) and therapeutics thereof |
| 04/18/1996 | CA2202088A1 Hepatitis virus vaccines |
| 04/18/1996 | CA2202066A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 04/18/1996 | CA2201935A1 Peptides and pharmaceutical compositions comprising them |
| 04/18/1996 | CA2201721A1 Microorganisms as therapeutic delivery systems |
| 04/18/1996 | CA2201592A1 Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system |
| 04/18/1996 | CA2201132A1 Cytokine designated lerk-6 |
| 04/18/1996 | CA2196991A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 04/17/1996 | EP0707077A2 Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same |
| 04/17/1996 | EP0707071A1 Recombinant vectors derived from adenovirus for use in gene therapy |
| 04/17/1996 | EP0707069A2 Process for preparing virus-resistant transgenic plant |
| 04/17/1996 | EP0707067A2 A novel gene coding thrombin-like protease |
| 04/17/1996 | EP0707065A2 Parietaria allergens |
| 04/17/1996 | EP0706799A2 Immunoconjugates II |
| 04/17/1996 | EP0706798A1 Pharmaceutical composition containing biologically active peptide or protein |
| 04/17/1996 | EP0706657A1 Inhibiting protein interactions |
| 04/17/1996 | EP0706656A1 Immunoassay for soluble fibrin polymers |